SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-110831
Filing Date
2020-04-17
Accepted
2020-04-17 17:30:38
Documents
17
Period of Report
2020-06-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A d904021dpre14a.htm PRE 14A 842927
2 GRAPHIC g904021g11v36.jpg GRAPHIC 25536
3 GRAPHIC g904021g13n12.jpg GRAPHIC 191452
4 GRAPHIC g904021g13n24.jpg GRAPHIC 45134
5 GRAPHIC g904021g13n25.jpg GRAPHIC 47859
6 GRAPHIC g904021g13n26.jpg GRAPHIC 117098
7 GRAPHIC g904021g13n29.jpg GRAPHIC 169769
8 GRAPHIC g904021g21o68.jpg GRAPHIC 33472
9 GRAPHIC g904021g24x13.jpg GRAPHIC 50550
10 GRAPHIC g904021g31b13.jpg GRAPHIC 108642
11 GRAPHIC g904021g31v29.jpg GRAPHIC 280370
12 GRAPHIC g904021g42q58.jpg GRAPHIC 43941
13 GRAPHIC g904021g51g39.jpg GRAPHIC 48446
14 GRAPHIC g904021g54t01.jpg GRAPHIC 47903
15 GRAPHIC g904021g59t88.jpg GRAPHIC 139188
16 GRAPHIC g904021g62v71.jpg GRAPHIC 37034
17 GRAPHIC g904021g83r33.jpg GRAPHIC 38914
  Complete submission text file 0001193125-20-110831.txt   2773488
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-19879 | Film No.: 20800700
SIC: 2834 Pharmaceutical Preparations